Literature DB >> 18237268

Infection with human papillomavirus and HIV among young women in Kampala, Uganda.

Cecily Banura1, Silvia Franceschi, Leen-Jan van Doorn, Annie Arslan, Fred Wabwire-Mangen, Edward K Mbidde, Wim Quint, Elisabete Weiderpass.   

Abstract

BACKGROUND: Information on the prevalence of cervical infection with different human papillomavirus (HPV) types among young women is essential to support the introduction of HPV vaccine in Uganda.
METHODS: Cross-sectional findings are presented from a cohort study of 1,275 sexually active women aged 12-24 years seeking health services at a clinic for teenagers in Kampala, Uganda. We assessed the presence of 39 HPV types by use of highly sensitive polymerase chain reaction assays.
RESULTS: The prevalence of HPV infection was 74.6%, and the prevalence of human immunodeficiency virus infection was 8.6%. High-risk HPV types were found in 51.4% of women, and the most frequently detected high-risk types were, in decreasing order, HPV 52, 51, 18, and 16. A total of 71.8% of the women who were positive for HPV 16 and/or 18 were also infected with other high-risk HPV types. HIV-positive women had a higher prevalence of HPV infection (87.8% vs 73.2%) and of multiple-type infections (64.6% vs 37.3%), compared with HIV-negative women. Employment in the tertiary sector, lifetime number of sexual partners, concurrent pregnancy, and the presence of genital warts were significantly associated with HPV positivity.
CONCLUSIONS: The prevalence of HPV infection is high among young women in Kampala, Uganda. Clinics for teenagers provide an opportunity to monitor the impact of HPV vaccines and, possibly, to catch up unvaccinated young women who have recently become sexually active.

Entities:  

Mesh:

Year:  2008        PMID: 18237268     DOI: 10.1086/526792

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Authors:  Iain J Macleod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L Shapiro; Mukendi Kayembe; Erik van Widenfelt; Joseph Makhema; M Essex; Carolyn Wester
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

2.  Effect of school-based human papillomavirus (hpv) vaccination on adolescent girls' knowledge and acceptability of the HPV vaccine in Ibanda District in Uganda.

Authors:  Andrew Kampikaho Turiho; Elialilia S Okello; Wilson W Muhwezi; Steve Harvey; Pauline Byakika-Kibwika; David Meya; Anne R Katahoire
Journal:  Afr J Reprod Health       Date:  2014-12

3.  High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.

Authors:  Deepa Reddy; Joseph Njala; Penny Stocker; Alan Schooley; Martiniano Flores; Chi-Hong Tseng; Colin Pfaff; Perry Jansen; Ronald T Mitsuyasu; Risa M Hoffman
Journal:  Int J STD AIDS       Date:  2014-06-13       Impact factor: 1.359

4.  Oncogenic HPV among HIV infected female population in West Bengal, India.

Authors:  Kamalesh Sarkar; Reshmi Pal; Baishali Bal; Bibhuti Saha; Subhasish Bhattacharya; Sharmila Sengupta; Partha Pratim Mazumdar; Shekhar Chakraborti
Journal:  BMC Infect Dis       Date:  2011-03-22       Impact factor: 3.090

5.  Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Authors:  Doreen Ramogola-Masire; Cindy M McGrath; Kurt T Barnhart; Harvey M Friedman; Nicola M Zetola
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

6.  Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.

Authors:  Nelly Mugo; Nana Akosua Ansah; Deborah Marino; Alfred Saah; Elizabeth I O Garner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Prevalence and correlates of genital warts in Kenyan female sex workers.

Authors:  Barbara E Kavanaugh; Katherine Odem-Davis; Walter Jaoko; Benson Estambale; James N Kiarie; Linnet N Masese; Ruth Deya; Lisa E Manhart; Susan M Graham; Raymond Scott McClelland
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

8.  Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Authors:  Cecily Banura; Sven Sandin; Leen-Jan van Doorn; Wim Quint; Bernhard Kleter; Fred Wabwire-Mangen; Edward K Mbidde; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2010-04-09       Impact factor: 2.965

9.  Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.

Authors:  Twaha Mutyaba; Florence Mirembe; Sven Sandin; Elisabete Weiderpass
Journal:  Reprod Health       Date:  2010-05-10       Impact factor: 3.223

10.  Differences in the risk of cervical cancer and human papillomavirus infection by education level.

Authors:  S Franceschi; M Plummer; G Clifford; S de Sanjose; X Bosch; R Herrero; N Muñoz; S Vaccarella
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.